Literature DB >> 27083473

CD8(+) T cells remove cysts of Toxoplasma gondii from the brain mostly by recognizing epitopes commonly expressed by or cross-reactive between type II and type III strains of the parasite.

Eri Ochiai1, Qila Sa1, Sara Perkins1, Michael E Grigg2, Yasuhiro Suzuki3.   

Abstract

Our previous study demonstrated that CD8(+) T cells remove cysts of Toxoplasma gondii from the brain through perforin-mediated mechanisms. We here show that a transfer of CD8(+) immune T cells primed with a type II or a type III strain of T. gondii both efficiently removed cysts of a type II strain from infected SCID mice, although the former tended to be slightly more efficient than the latter. Similarly, a transfer of type II-primed CD8(+) T cells removed cysts of a type III strain. Therefore, CD8(+) T cells are capable of removing T. gondii cysts by recognizing epitopes commonly expressed in types II and III strains or cross-reactive between these two genotypes.
Copyright © 2016. Published by Elsevier Masson SAS.

Entities:  

Keywords:  CD8(+) T cells; Cyst; Genotype; Perforin; Toxoplasma gondii

Mesh:

Substances:

Year:  2016        PMID: 27083473      PMCID: PMC4927374          DOI: 10.1016/j.micinf.2016.03.013

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  20 in total

1.  Brain cancer mortality rates increase with Toxoplasma gondii seroprevalence in France.

Authors:  Marion Vittecoq; Eric Elguero; Kevin D Lafferty; Benjamin Roche; Jacques Brodeur; Michel Gauthier-Clerc; Dorothée Missé; Frédéric Thomas
Journal:  Infect Genet Evol       Date:  2012-01-25       Impact factor: 3.342

Review 2.  Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain.

Authors:  Yasuhiro Suzuki; Qila Sa; Marie Gehman; Eri Ochiai
Journal:  Expert Rev Mol Med       Date:  2011-10-04       Impact factor: 5.600

3.  Strains of Toxoplasma gondii used for tachyzoite antigens to stimulate spleen cells of infected mice in vitro affect cytokine responses of the cells in the culture.

Authors:  Laurel Rodgers; Xisheng Wang; Xiangshu Wen; Bradley Dunford; Renee Miller; Yasuhiro Suzuki
Journal:  Parasitol Res       Date:  2005-07-07       Impact factor: 2.289

4.  VCAM-1/α4β1 integrin interaction is crucial for prompt recruitment of immune T cells into the brain during the early stage of reactivation of chronic infection with Toxoplasma gondii to prevent toxoplasmic encephalitis.

Authors:  Qila Sa; Eri Ochiai; Tomoko Sengoku; Melinda E Wilson; Morgan Brogli; Stephen Crutcher; Sara A Michie; Baohui Xu; Laura Payne; Xisheng Wang; Yasuhiro Suzuki
Journal:  Infect Immun       Date:  2014-04-21       Impact factor: 3.441

Review 5.  Toxoplasmosis in the non-AIDS immunocompromised host.

Authors:  D M Israelski; J S Remington
Journal:  Curr Clin Top Infect Dis       Date:  1993

6.  Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis.

Authors:  D K Howe; S Honoré; F Derouin; L D Sibley
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

7.  Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease.

Authors:  D K Howe; L D Sibley
Journal:  J Infect Dis       Date:  1995-12       Impact factor: 5.226

Review 8.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

9.  Immune profiling of pregnant Toxoplasma-infected US and Colombia patients reveals surprising impacts of infection on peripheral blood cytokines.

Authors:  Lena Pernas; Raymund Ramirez; Tyson H Holmes; José G Montoya; John C Boothroyd
Journal:  J Infect Dis       Date:  2014-03-23       Impact factor: 5.226

10.  Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells.

Authors:  Yasuhiro Suzuki; Xisheng Wang; Benard S Jortner; Laura Payne; Yanyan Ni; Sara A Michie; Baohui Xu; Tomoya Kudo; Sara Perkins
Journal:  Am J Pathol       Date:  2010-02-18       Impact factor: 4.307

View more
  6 in total

Review 1.  A review on inactivation methods of Toxoplasma gondii in foods.

Authors:  Adel Mirza Alizadeh; Sahar Jazaeri; Bahar Shemshadi; Fataneh Hashempour-Baltork; Zahra Sarlak; Zahra Pilevar; Hedayat Hosseini
Journal:  Pathog Glob Health       Date:  2018-10-22       Impact factor: 2.894

2.  Determination of a Key Antigen for Immunological Intervention To Target the Latent Stage of Toxoplasma gondii.

Authors:  Qila Sa; Eri Ochiai; Ashish Tiwari; Jeremi Mullins; Nilabh Shastri; Corinne Mercier; Marie-France Cesbron-Delauw; Yasuhiro Suzuki
Journal:  J Immunol       Date:  2017-04-26       Impact factor: 5.422

3.  PD-L1, TIM-3, and CTLA-4 Blockade Fails To Promote Resistance to Secondary Infection with Virulent Strains of Toxoplasma gondii.

Authors:  Samantha D Splitt; Scott P Souza; Kristen M Valentine; Brayan E Castellanos; Andrew B Curd; Katrina K Hoyer; Kirk D C Jensen
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

Review 4.  A pathway to cure chronic infection with Toxoplasma gondii through immunological intervention.

Authors:  Yasuhiro Suzuki
Journal:  Parasitol Int       Date:  2020-12-01       Impact factor: 2.230

5.  Selective Upregulation of Transcripts for Six Molecules Related to T Cell Costimulation and Phagocyte Recruitment and Activation among 734 Immunity-Related Genes in the Brain during Perforin-Dependent, CD8+ T Cell-Mediated Elimination of Toxoplasma gondii Cysts.

Authors:  Jenny Lutshumba; Eri Ochiai; Qila Sa; Namrata Anand; Yasuhiro Suzuki
Journal:  mSystems       Date:  2020-04-14       Impact factor: 6.496

6.  Expression of TIGIT in splenic and circulatory T cells from mice acutely infected with Toxoplasma gondii.

Authors:  Shuai Wang; Haoran Li; Fuqiang Zhang; Yuankai Jiao; Qing Xie; Zhenchao Zhang; Xiangrui Li
Journal:  Parasite       Date:  2021-02-25       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.